Patco Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 K
as on 06-12-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 401.28%
(FY 2021)
- Profit 1063.36%
(FY 2021)
- Ebitda 737.98%
(FY 2021)
- Net Worth 377.33%
(FY 2021)
- Total Assets 123.86%
(FY 2021)
About Patco Pharmaceuticals
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 K , as per Ministry of Corporate Affairs (MCA) records.
Deepak Gajjar, Jyoti Gajjar, Harsh Deepak, and One other member serve as directors at the Company.
- CIN/LLPIN
U52609MH2019PTC322067
- Company No.
322067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Patco Pharmaceuticals Private Limited offer?
Patco Pharmaceuticals Private Limited offers a wide range of products and services, including Filling Machines, Bottle Sealing Machines, Resin, Hydrophobic Silica Gel, Seals, Sealing Wads, Miscel, Manual Encapsulation Machine, Phmach, Manual Capsule Filling Machine.
Who are the key members and board of directors at Patco Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harsh Deepak  | Director | 01-Mar-2019 | Current |
| Deepak Gajjar | Director | 01-Mar-2019 | Current |
| Jyoti Gajjar | Director | 01-Mar-2019 | Current |
| Charmi Gajjar | Director | 20-Dec-2023 | Current |
Financial Performance and Corporate Structure Insights of Patco Pharmaceuticals.
Patco Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 401.28% increase. The company also saw a substantial improvement in profitability, with a 1063.36% increase in profit. The company's net worth Soared by an impressive increase of 377.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Patco Pharmaceuticals?
Unlock access to Patco Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Patco Exports Pvt LtdActive 32 years 4 monthsDeepak Gajjar, Jyoti Gajjar and 2 more are mutual person
Indian Textile Accessories And Machinery Manufacturers' AssociationActive 55 years 5 monthsDeepak Gajjar is a mutual person
Elicura Healthcare LlpActive 1 year 1 monthDeepak Gajjar, Harsh Deepak and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Patco Pharmaceuticals?
Unlock and access historical data on people associated with Patco Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Patco Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Patco Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
